Cardiogenic Shock
Cardiogenic Shock
Henry L. Green, FACC, FACP
Incidence
7% of patients with myocardial infarction.
Commonest cause of death in myocardial infarction.
Most common with ST elevation myocardial infarctions.
Only 10-15% present initially with shock, offering an opportunity to prevent it by reperfusion therapy, such as primary percutaneous intervention.
Management
Support measures
Used to help stabilize patient prior to and during revascularization to prevent end organ damage
Vasopressors
Dopamine or norepinephrine, depending on degree of hypotension at minimum dose required
Dobutamine alone or with dopamine may be combined if hypoperfusion is not accompanied by
frank hypotension.
Intraortic balloon pump – if possible, apply before transfer
Mechanical ventilation
Monitor ECG
Emergency drugs and defibrillator
Temporary pacemaker at hand
Lowering core temperature to 33° C may be helpful
Left ventricular assist device
Revascularization
Angioplasty or bypass grafting associated with better outcomes than intensive medical therapy. (Mortality about 30% with revascularization, 75% with medical therapy in GUSTO-I trial)
Should be done as early as possible, but there is no absolute time window.
Invasive treatment usually reserved for patients younger than 75 years. However, in selected patients (“physiologically younger”), invasive treatment is not always ruled out. Consider comorbidities, duration of shock, coronary anatomy, recency of MI.
Repair of mechanical defects
Septal rupture, mitral regurgitation
Specific forms of cardiogenic shock
Extensive myocardial infarction
Accounts for majority of patients with cardiogenic shock
Myocardial rupture
Incidence
3% of patients, commoner in elderly women, hypertensives, and those with poor collaterals
Usually no prior infarct.
Usually 1-4 days after onset, but can be up to 3 weeks
Acute rupture is usually rapidly fatal
Subacute rupture with pseudoaneurysm formation
Nausea, hypotension, pericardial pain
Jugular venous distention, pulsus paradoxicus, pericardial rub and new to-and-fro murmur may be found.
Symptoms
Angina, pleuritic pr pericardial pain
Syncope, hypotension
Arrhythmias
Nausea, restlessness, hypotension
Physical examination
Jugular venous distention (29%)
Pulsus paradoxicus (47%)
Electromechanical dissociation
Cardiogenic shock
Sudden death
Echocardiogram
Pericardial effusion with high-acoustic echoes (blood clot) -- not always visualized
Direct visualization of tear
Signs of tamponade
Right heart catheterization
Ventriculography insensitive
Signs of tamponade not always present
Treatment
Pericardiocentesis may temporarily relieve tamponade if present
Prompt surgery
Ventricular septal rupture
Incidence
Up to 4% of myocardial infarctions, usually 3-7 days after onset but may be earlier
Risk factors: hypertension, advanced age, female sex, absence of prior angina or MI
May occur with anterior, inferior or posterior infarcts, more often with anterior infarcts
Results in a large left to right shunt. This may decrease as left ventricle fails.
20% are associated with severe mitral regurgitation
Symptoms
Chest pain, dyspnea, symptoms of low output and shock
Physical examination
Pansystolic murmur, usually lower left sternal border
Usually loud, sometimes with thrill. With shock, murmur may be hard to identify
Often right and left ventricular gallops (S3). Pulmonic second sound accentuated
Right and left ventricular failure
Cardiogenic shock
Echocardiogram
Ventricular septal rupture
Left to right shunt
Right ventricular overload
Right heart catheterization
Increase in oxygen saturation from right atrium to right ventricle
Large V waves
Treatment
Medical
Intraortic balloon pump
Afterload reduction, nitroprusside
Diuretics
Usually inotropic agents
Oxygen (mask, CPAP, BIPAP or intubation)
Surgery
Usually required and best done early
Closure of defect and reconstruction of ventricle
Coronary artery bypass grafting
Prognosis
Roughly 50% mortality. Of those who survive surgery, 5-year survival is 70%
Acute severe mitral regurgitation
Incidence
Usually 2-7 days after the infarct
Usually with inferior infarcts (posteromedial papillary muscle has single artery, anterior muscle , has dual supply.)
Often due to papillary muscle dysfunction, less often papillary muscle rupture
Symptoms
Abrupt onset of shortness of breath, pulmonary edema; hypotension
Physical examination
Pansystolic murmur, usually apex.
May or may not be loud, rarely with a thrill
Variable signs of right ventricular overload
Severe pulmonary edema
Cardiogenic shock
Echocardiogram
Hypercontractile left ventricle
Torn papillary muscle or chordae tendineae
Flail mitral leaflet
Severe mitral regurgitation
Right heart catheterization
No increase in oxygen saturation from right atrium to right ventricle
Large V waves
Very high pulmonary capillary wedge pressure
Treatment
Medical therapy is generally a bridge to surgery
Vasodilators (e.g. sodium nitroprusside)
Intraortic balloon pump
Surgery
Mitral valve replacement or repair
Coronary bypass
Right ventricular infarction
Incidence
Occurs in nearly 50% of inferior infarcts
Physical examination
Hypotension, clear lungs and jugular venous distention (also found in pericardial tamponade, constrictive pericarditis, restrictive cardiomyopathy and large pulmonary embolus)
Unexpected drop in BP on administration of nitroglycerine
Kussmaul sign in presence of inferior infarct strongly suggests right ventricular infarction
ECG:
ST elevation in right precordial leads, especially V4r. May persist only 10-12 hours
Echocardiogram:
Increased right ventricular dimension
Treatment:
Avoid nitroglycerine
IV saline
Atrioventricular pacing if high grade AV block
Dobutamine
Intraortic balloon pump
Revascularization
Systolic anterior motion of anterior leaflet of mitral valve causing left ventricular outflow tract obstruction
Believed to be due to compensatory hyperkinesis of non-infarcted myocardium
Clinical
Systolic murmur
Hypotension
Echocardiogram:
Systolic motion of anterior mitral leaflet
Left ventricular outflow gradient
Treatment:
Avoid afterload reducing agents, vasodilators and inotropes
Beta blockers presumably to reduce hyperkinesis
Alpha agonists increase systemic vascular resistance and left ventricular volume
Postoperative course of patients operated on for septal rupture or severe mitral regurgitation is stormy, complicated by
Cardiogenic shock
Metabolic acidosis
Acute renal failure
Coagulopathy
Catabolic state
Deconditioning
Multiorgan failure
Malnutrition
Outcome
30 day mortality 47% with invasive treatment, 56% with conservative treatment
In those who survived 30 days, 85% were alive at 1 year. 83% of the survivors were in NYHA Class I or II at 1 year.
References
Reviews in Cardiovascular Medicine 2003 4:131
Heart 2002, 88:531
Haley JH, Sinak LJ, Tajik AJ, Ommen SR, Oh JK. Dynamic left ventricular outflow tract obstruction in acute coronary syndromes: an important cause of new systolic murmur and cardiogenic shock. Mayo Clin
Proc. 1999;74:901-906.
Topol, Textbook of Cardiovascular Medicine, 2nd ed.
Braunwald, Heart Disease, 6th ed.
1 Comments:
Defibrillators are an important thing for the medical industry. Having one that is a personal Defibrillator is even more important than usual if you have a loved one that suffers from a known heart condition Defibrillators can be a true life saving thing to have around.
Post a Comment
<< Home